MindWalk Holdings (HYFT) Gross Profit Growth (1y) (2021 - 2026)
MindWalk Holdings (HYFT) Gross Profit Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 11.24% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 15.59% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 68.41% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 33.01% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -41.93% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 57.16% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 351.57% |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -100.00% |
| Jan 31, 2026 | 43.13% |
| Oct 31, 2025 | 191,318.82% |
| Jul 31, 2025 | -99.85% |
| Apr 30, 2025 | 87,666.56% |
| Jan 31, 2025 | -47.55% |
| Oct 31, 2024 | 45,916.85% |
| Jul 31, 2024 | 35,124.76% |
| Apr 30, 2024 | -244.96% |
| Jan 31, 2024 | 7.62% |
| Oct 31, 2023 | -99.90% |
| Jul 31, 2023 | 7.47% |
| Apr 30, 2023 | -5.69% |
| Jan 31, 2023 | -21.92% |
| Oct 31, 2022 | 94,212.33% |
| Jul 31, 2022 | 95,421.29% |
| Apr 30, 2022 | 118,696,394.12% |
| Jan 31, 2022 | 1.64% |
| Oct 31, 2021 | -99.89% |
| Jul 31, 2021 | -99.88% |